reiterateLPLAfinnhub
JP Morgan Reiterates Overweight Rating on LPL Financial Holdings Inc. (LPLA)
JP Morgan reiterated its Overweight rating on LPL Financial Holdings Inc. (NASDAQ:LPLA) on October 07, 2026.
Read moreFeatured By
Real-time context
Follow the latest analyst actions, insider and institutional activity, earnings, dividends, price moves, and company filings.
JP Morgan reiterated its Overweight rating on LPL Financial Holdings Inc. (NASDAQ:LPLA) on October 07, 2026.
Read moreBarclays reiterated its Overweight rating on LPL Financial Holdings Inc. (NASDAQ:LPLA) on October 07, 2026.
Read moreUBS reiterated its Buy rating on LPL Financial Holdings Inc. (NASDAQ:LPLA) on October 07, 2026.
Read moreRaymond James analysts initiated coverage on M&T Bank Corporation (NYSE:MTB) with a rating of Outperform on October 07, 2026.
Read moreBrookline Capital analysts initiated coverage on Biomea Fusion, Inc. (NASDAQ:BMEA) with a rating of Buy on October 07, 2026.
Read moreStoneX reiterated its Buy rating on OmniAb, Inc. (NASDAQ:OABI) on October 07, 2026.
Read moreLeerink Partners reiterated its Outperform rating on OmniAb, Inc. (NASDAQ:OABI) on October 07, 2026.
Read moreMacquarie reiterated its Neutral rating on Inspired Entertainment, Inc. (NASDAQ:INSE) on October 07, 2026.
Read moreJefferies reiterated its Hold rating on Oportun Financial Corporation (NASDAQ:OPRT) on October 07, 2026.
Read moreMacquarie reiterated its Neutral rating on Isabella Bank Corporation (NASDAQ:ISBA) on October 07, 2026.
Read moreChardan Capital reiterated its Buy rating on Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) on October 07, 2026.
Read moreWedbush reiterated its Outperform rating on Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) on October 07, 2026.
Read moreLeerink Partners reiterated its Market Perform rating on Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) on October 07, 2026.
Read moreHC Wainwright & Co. reiterated its Buy rating on Vir Biotechnology, Inc.
Read moreMacquarie reiterated its Outperform rating on Accel Entertainment, Inc. (NYSE:ACEL) on October 07, 2026.
Read moreBTIG reiterated its Buy rating on MFA Financial, Inc. (NYSE:MFA) on October 07, 2026.
Read moreBTIG reiterated its Buy rating on ArriVent BioPharma, Inc. Common Stock (NASDAQ:AVBP) on October 07, 2026.
Read moreGuggenheim reiterated its Buy rating on ArriVent BioPharma, Inc. Common Stock (NASDAQ:AVBP) on October 07, 2026.
Read moreCitigroup reiterated its Buy rating on ArriVent BioPharma, Inc. Common Stock (NASDAQ:AVBP) on October 07, 2026.
Read moreJones Trading reiterated its Buy rating on ArriVent BioPharma, Inc. Common Stock (NASDAQ:AVBP) on October 07, 2026.
Read more